Memorial Sloan Kettering Cancer Commack — Commack, New York

Public research footprint of Memorial Sloan Kettering Cancer Commack, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Lung Cancer · Transformed Follicular Lymphoma to Diffuse Large B Cell Lymphoma · NSCLC Stage II · Metastatic Prostate Cancer

Recently updated registry entries

NCT03999710 — Determining Whether Durvalumab in Combination With Radiation Therapy Can Prevent the… (Active Not Recruiting)
NCT03143270 — A Study to Test the Safety and Feasibility of Nivolumab With Drug Eluting Bead… (Completed)
NCT01775072 — Genomic Profiling in Cancer Patients (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Memorial Sloan Kettering Cancer Commack?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.